Wells Fargo & Company Atossa Therapeutics, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 71,720 shares of ATOS stock, worth $55,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,720

Previous 54,867 30.72%

Holding current value

$55,224

Previous $83,000 19.28%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$0.94 - $1.62 $15,841 - $27,301	16,853 Added 30.72%	71,720 $67,000
Q3 2024 Nov 13, 2024	BUY	$1.09 - $1.52 $1,964 - $2,739	1,802 Added 3.4%	54,867 $83,000
Q2 2024 Aug 13, 2024	BUY	$1.03 - $2.1 $53,708 - $109,502	52,144 Added 5661.67%	53,065 $63,000
Q1 2024 May 10, 2024	BUY	$0.8 - $1.89 $8 - $20	11 Added 1.21%	921 $1,000
Q4 2023 Feb 09, 2024	BUY	$0.63 - $0.98 $26 - $41	42 Added 4.84%	910 $0
Q3 2023 Nov 13, 2023	SELL	$0.74 - $1.35 $3,099 - $5,655	-4,189 Reduced 82.84%	868 $0
Q2 2023 Aug 15, 2023	BUY	$0.6 - $1.28 $20 - $43	34 Added 0.68%	5,057 $6,000
Q1 2023 May 12, 2023	BUY	$0.59 - $0.91 $2,485 - $3,832	4,212 Added 519.36%	5,023 $3,000
Q4 2022 Feb 13, 2023	BUY	$0.5 - $1.01 $10 - $21	21 Added 2.66%	811 $0
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $46 - $64	-57 Reduced 6.73%	790 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.28 $20,477 - $30,836	-24,091 Reduced 96.6%	847 $1,000
Q1 2022 May 16, 2022	SELL	$1.11 - $1.74 $45,192 - $70,842	-40,714 Reduced 62.01%	24,938 $32,000
Q4 2021 Feb 14, 2022	BUY	$1.6 - $3.27 $105,043 - $214,682	65,652 New	65,652 $105,000
Q3 2021 Nov 15, 2021	SELL	$2.89 - $6.4 $3,363 - $7,449	-1,164 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.52 - $8.62 $304 - $1,723	200 Added 20.75%	1,164 $7,000
Q1 2021 May 13, 2021	BUY	$0.92 - $4.33 $824 - $3,879	896 Added 1317.65%	964 $2,000
Q4 2020 Feb 09, 2021	BUY	$0.85 - $2.43 $3 - $9	4 Added 6.25%	68 $0
Q3 2020 Nov 05, 2020	BUY	$1.98 - $4.35 $5 - $13	3 Added 4.92%	64 $0
Q1 2020 May 14, 2020	BUY	$0.79 - $1.62 $48 - $98	61 New	61 $0

Others Institutions Holding ATOS

# of Institutions

Shares Held

29M

Call Options Held

39.8K

Put Options Held

90.9K

View Full List

About ATOSSA THERAPEUTICS, INC.

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $97.5M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

More about ATOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Atossa Therapeutics, Inc. Transaction History